Dolby Laboratories (DLB) Cash from Investing Activities Growth (3y) (2016 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Relx |
81.40 Bn |
81.16 Bn |
- |
- |
| 2 |
Rentokil Initial |
79.56 Bn |
78.10 Bn |
- |
- |
| 3 |
Cintas |
69.26 Bn |
69.08 Bn |
1.45 Bn |
-1.31% |
| 4 |
Copart |
33.09 Bn |
28.01 Bn |
971.24 Mn |
13.75% |
| 5 |
UL Solutions |
20.56 Bn |
20.32 Bn |
381.00 Mn |
6.66% |
| 6 |
Global Payments |
19.88 Bn |
14.69 Bn |
1.70 Bn |
49.76% |
| 7 |
Rb Global |
19.08 Bn |
18.89 Bn |
869.50 Mn |
69.67% |
| 8 |
Aramark |
13.57 Bn |
13.16 Bn |
426.35 Mn |
-6.98% |
| 9 |
Amentum Holdings |
5.65 Bn |
5.74 Bn |
345.00 Mn |
- |
| 10 |
Dolby Laboratories |
5.15 Bn |
4.56 Bn |
350.90 Mn |
-58.13% |
| Date | Value |
| Mar 27, 2026 |
-58.13% |
| Dec 26, 2025 |
-64.70% |
| Sep 26, 2025 |
18.66% |
| Jun 27, 2025 |
7.65% |
| Mar 28, 2025 |
30.34% |
| Dec 27, 2024 |
59.88% |
| Sep 27, 2024 |
-159.48% |
| Jun 28, 2024 |
18.28% |
| Mar 29, 2024 |
-7.82% |
| Dec 29, 2023 |
34.30% |
| Sep 29, 2023 |
-28.61% |
| Jun 30, 2023 |
-6.49% |
| Mar 31, 2023 |
63.94% |
| Dec 30, 2022 |
40.21% |
| Sep 30, 2022 |
-63.65% |
| Jul 1, 2022 |
6.13% |
| Apr 1, 2022 |
-76.79% |
| Dec 31, 2021 |
-44.77% |
| Sep 24, 2021 |
-33.86% |
| Jun 25, 2021 |
-32.34% |
| Mar 26, 2021 |
-37.85% |
| Dec 25, 2020 |
61.90% |
| Sep 25, 2020 |
97.89% |
| Jun 26, 2020 |
34.40% |
| Mar 27, 2020 |
38.18% |
| Dec 27, 2019 |
-11.96% |
| Sep 27, 2019 |
28.25% |
| Jun 28, 2019 |
43.62% |
| Mar 29, 2019 |
-65.79% |
| Dec 28, 2018 |
19.59% |
| Sep 28, 2018 |
-9.79% |
| Jun 29, 2018 |
36.57% |
| Mar 30, 2018 |
35.49% |
| Dec 29, 2017 |
40.07% |
| Sep 29, 2017 |
34.01% |
| Jun 30, 2017 |
-10.32% |
| Mar 31, 2017 |
-15.74% |
| Dec 30, 2016 |
10.88% |
| Sep 30, 2016 |
-136.38% |
| Jul 1, 2016 |
-194.63% |